Raymond James & Associates’s JPMorgan US Value Factor ETF JVAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.3M Buy
29,760
+1,447
+5% +$60.7K ﹤0.01% 2512
2024
Q2
$1.16M Buy
28,313
+1,271
+5% +$51.6K ﹤0.01% 2531
2024
Q1
$1.13M Sell
27,042
-986
-4% -$38.9K ﹤0.01% 2522
2023
Q4
$1.08M Sell
28,028
-6,434
-19% -$229K ﹤0.01% 2469
2023
Q3
$1.19M Buy
34,462
+358
+1% +$12.9K ﹤0.01% 2348
2023
Q2
$1.22M Buy
34,104
+439
+1% +$15K ﹤0.01% 2365
2023
Q1
$1.15M Buy
33,665
+14,429
+75% +$496K ﹤0.01% 2377
2022
Q4
$637K Sell
19,236
-3,982
-17% -$131K ﹤0.01% 2720
2022
Q3
$691K Sell
23,218
-166
-0.7% -$5.53K ﹤0.01% 2627
2022
Q2
$751K Sell
23,384
-503
-2% -$17.5K ﹤0.01% 2639
2022
Q1
$883K Sell
23,887
-232
-1% -$8.6K ﹤0.01% 2688
2021
Q4
$927K Buy
24,119
+15,198
+170% +$569K ﹤0.01% 2663
2021
Q3
$317K Buy
+8,921
New +$326K ﹤0.01% 3369

Other funds holding JVAL

Raymond James & Associates's JVAL Position: Q3 2024 in Review

Raymond James & Associates increased its JPMorgan US Value Factor ETF (JVAL) stake by 5.1% in Q3 2024, buying an estimated $60.7K and bringing the position to 29,760 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2512.

Raymond James & Associates first reported a position in JVAL in Q3 2021 and has held it in 13 quarters since. 115 funds tracked by Wall St. Rank hold JVAL as of Q3 2024.

  • Raymond James & Associates held 29,760 shares of JPMorgan US Value Factor ETF worth $1.3M as of Q3 2024.
  • Raymond James & Associates bought 1,447 JPMorgan US Value Factor ETF shares in Q3 2024, an estimated $60.7K.
  • JPMorgan US Value Factor ETF made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2512 holding.
  • Raymond James & Associates first reported a position in JPMorgan US Value Factor ETF in Q3 2021 and has held it in 13 quarters since.
  • 115 funds tracked by Wall St. Rank held JPMorgan US Value Factor ETF as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.